Substituted imidazo[1,2-a]pyrazines, pyrazolo[1,5-c]pyrimidines, pyrazolo[1,5-a]pyridines, and purines for the treatment of schistosomiasis
申请人:Merck Patent GmbH
公开号:US11046700B2
公开(公告)日:2021-06-29
The present invention relates to compounds of formula (1a), formula (1b), formula (1c) or formula (1d):
or, or a pharmaceutically acceptable salt thereof, which have activity as inhibitors of Schistosoma growth. The invention also relates to pharmaceutical compositions comprising such compounds, salts or solvates and to the use of such compounds as medicaments, in particular in the treatment or prevention of schistosomiasis, also known as bilharzia.
本发明涉及式(1a)、式(1b)、式(1c)或式(1d)化合物:
或其药学上可接受的盐,它们具有抑制血吸虫生长的活性。本发明还涉及包含此类化合物、盐或溶液的药物组合物,以及此类化合物作为药物的用途,特别是在治疗或预防血吸虫病(又称血吸虫病)方面的用途。